P2X7 ANTAGONISTS AS FRONTLINE OR ADJUNCTIVE TREATMENT AGAINST STATUS EPILEPTICUS

摘要

P2X7 antagonists as frontline or adjunctive treatment against status epilepticus. It is shown that P2X7 antagonists can be used for frontline or adjunctive treatment for the ameloration or termination or status epilepticus and neonatal seizures, especially refractory status epilepticus or neonatal seizures. Combination with current anticonvulsants, particularly GABA-based anticonvulsants such as benzodiazepines or barbiturates, results in the effective termination of status epilepticues, even when it is refractory.